Celegene to file suit over Natco's Revlimid copy; DOJ forced Allergan to withdraw FDA suit

@FiercePharma: Allergan inks $600M off-label settle. Article | Follow @FiercePharma

> Celgene says it plans to file a patent-infringement suit against India's Natco Pharma, which has submitted a request to the FDA for authorization to make and sell generic versions of Celgene's cancer drug Revlimid. Report

> Before Allergan could begin settlement negotiations with the Department of Justice--which ended with an agreement to pay $600 million on Wednesday--DOJ required the Botox manufacturer to first withdraw a First Amendment lawsuit against the FDA filed last October. Report

> The FDA will allow Indian generics maker Lupin to seek approval for a generic version of Pfizer's blockbuster cholesterol drug Lipitor with a different formulation from the original drug. Report

> Sigma Pharmaceuticals expects to be hit with a shareholder class action lawsuit over its alleged failure to disclose its financial position before a capital raising in September 2009. Report

> By acquiring 25 percent of Cipla Medpro's manufacturing division, India's Cipla could play white knight for the South African drugmaker, a key ally of the Indian company. Report

> Over the previous decade, the proportion of Americans (of all ages) reporting they took a prescription drug in the past month rose to 48 percent from 44 percent. Report

> Quitting smoking may require longer treatment with drugs or couseling than doctors tend to provide, researchers found. Report

Biotech News

 @FierceBiotech: Nobel Prize-winner finds new path for Alzheimer's drug. Story | Follow @FierceBiotech

 @JohnCFierce: Forbion Capital raised €190 million for a new fund. Good news for European biotechs. | Follow @JohnCFierce

> Santhera, Ipsen ink fipamezole pact. News

> Pfizer returns brain cancer vax rights to Celldex. Report

> UAB spin-off's tech could shorten drug dev to 6 weeks. Article

> Cebix raises $16 million. Story

> Forbion raises $240 million investment fund. Item

And Finally... Scientists have figured out why fish oil is so good for you. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.